PHARMACYTE BIOTECH INC's ticker is and the CUSIP is 71715X903. A total of 3 filers reported holding PHARMACYTE BIOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 100 | -99.9% | 0.00% | – |
| Q4 2022 | $217 | -99.9% | 74,200 | -0.9% | 0.00% | – |
| Q3 2022 | $179,000 | +539.3% | 74,900 | +480.6% | 0.00% | – |
| Q2 2022 | $28,000 | +7.7% | 12,900 | +11.2% | 0.00% | – |
| Q1 2022 | $26,000 | +23.8% | 11,600 | +36.5% | 0.00% | – |
| Q4 2021 | $21,000 | – | 8,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 14,500 | $35,000 | 0.00% |
| SIMPLEX TRADING, LLC | 74,900 | $179,000 | 0.00% |